Topline results from the COMPETE trial showed that ITM-11 met the study’s primary end point of PFS in inoperable, progressive ...

Pennsylvania state leaders convened on Friday for a groundbreaking roundtable to address the critical intersection of ...

Portland Treatment Center in Maine provides a wide range of services for those struggling with mental health and substance ...

Approximately 1 in 5 people develop cancer in their lifetime, and it continues to be one of the leading causes of mortality ...

Roche’s PATHWAY HER2 (4B5) test helps identify patients with HER2-ultralow breast cancer, who may be eligible for targeted ...

Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

Celltrion, a major South Korean biopharmaceutical firm, on Friday said its new biosimilar for an autoimmune disease treatment has received approval from the US Food and Drug Administration (FDA). The ...

The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...

Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...

Trump prioritizes criminalization over public health in fighting the overdose crisis. Experts say that doesn't work ...

Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive, and often fatal lung disease characterized by the scarring (fibrosis) of lung tissue, ...

Doylestown Health is broadening its treatment options for atrial fibrillation patients with a revolutionary system that ...